A Prospective Randomized Double Blind Trial to Assess the Effect of a Single Preoperative Dose of Gabapentin on Postoperative Opioid Consumption in Patients Undergoing Rhinoplasty (NCT03498261)

🧪 Interventions in This Study

• Gabapentin (DRUG)
• Placebos (DRUG)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• The Ohio State University Wexner Medical Center — Columbus, Ohio

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Pain, Postoperative

• Comprehensive Study of Post-surgical Pain After Pectus or Spine Surgery — Cincinnati, Ohio
• Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial — Kansas City, Missouri
• Reduced Opioid Prescription After Laparoscopic Hysterectomy — Baltimore, Maryland
• Magnesium as an Adjuvant Agent for Postoperative Pain — Cleveland, Ohio
• Personalization of Opioid Prescription Following Orthognathic Surgery — Halifax, Nova Scotia

Explore by condition: All Pain, Postoperative clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.